Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Transplant Cell Ther. 2021 Feb 25;27(6):476.e1–476.e7. doi: 10.1016/j.jtct.2021.02.018

Figure 4. Diagram of treatment plan.

Figure 4.

Canine recipients were given three preceding transfusions of irradiated whole blood from DLA-identical marrow donors on days -24, -17, and -10. 211-At-labeled anti-CD45 mAb was given on day -3. TBI (9.2Gy) and bone marrow were given on day 0. Blood counts and chemistry were analyzed on days -7, -3, 0. They were evaluated daily until full hematopoietic recovery, then, once a week until the end of study.